Compare CubeSmart (CUBE) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CubeSmart vs Nuwellis Inc — how do they compare? CubeSmart trades at $37.93 (market cap $8.45B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: CubeSmart is far larger — about 3840.9× Nuwellis Inc's market cap, and CubeSmart pays a 5.65% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CubeSmart for 89 Days and Nuwellis Inc for 26 Days on average.
| CUBE | NUWE | |
|---|---|---|
Market Cap | $8.45B | $2.20M |
Volume | 2,879,532 | 121,544 |
Sector | Real Estate | Health |
52-Week High | $42.50 | $146.65 |
52-Week Low | $35.36 | $0.68 |
Typical Hold Time | 89 Days | 26 Days |
Enterprise Value | $11.97B | -$1.52M |
Dividend Yield | 5.65% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CubeSmart (CUBE) trades at $37.97, up 1.99% on the day, with a bearish technical outlook as moving averages signal selling pressure. The company reported mixed Q2 2026 results, with an FFO miss but revenue beat, and maintains strong profitability with a 29.41% net income margin. Recent news highlights institutional accumulation, with firms like NewEdge Advisors and Deutsche Bank increasing stakes, while analyst consensus leans toward Hold with a $44.00 price target.
The stock offers a 5.4% dividend yield and trades below the consensus target, suggesting potential upside if operational improvements materialize. Risks include high leverage with $2.99B in long-term debt and sensitivity to real estate market cycles. Earnings growth in H2 2026 is critical for reversing the current bearish sentiment.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
Read more on CUBE →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
